TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmor AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
247
|
332
|
268 |
| Financial expenses |
4
|
29
|
39 |
| Earnings before taxes |
128
|
145
|
83 |
| EBITDA |
114
|
148
|
117 |
| Total assets |
594
|
521
|
410 |
| Current assets |
116
|
132
|
171 |
| Current liabilities |
91
|
91
|
82 |
| Equity capital |
462
|
391
|
296 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.8%
|
75.0%
|
72.2% |
| Turnover per employee |
247
|
332
|
268 |
| Profit as a percentage of turnover |
51.8%
|
43.7%
|
31.0% |
| Return on assets (ROA) |
22.2%
|
33.4%
|
29.8% |
| Current ratio |
127.5%
|
145.1%
|
208.5% |
| Return on equity (ROE) |
27.7%
|
37.1%
|
28.0% |
| Change turnover |
-74
|
63
|
17 |
| Change turnover % |
-23%
|
24%
|
7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.